|
Volumn 18, Issue 4, 2004, Pages 405-411
|
Determination of Abacavir in maternal plasma, amniotic fluid, fetal and placental tissues by a polarity switching liquid chromatography/tandem mass spectrometry method
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
PARTICLE SIZE;
PRECIPITATION (CHEMICAL);
TISSUE;
ABACAVIR;
AMNIOTIC FLUID;
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
INTERNAL STANDARDS;
LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY;
MATERNAL PLASMAS;
MATRIX;
POLARITY SWITCHING;
TISSUE SAMPLES;
GRADIENT METHODS;
ABACAVIR;
ACETONITRILE;
AMMONIUM ACETATE;
ANTIVIRUS AGENT;
AZIDOURIDINE;
CARBOCYCLIC NUCLEOSIDE;
UNCLASSIFIED DRUG;
URIDINE DERIVATIVE;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
CONCENTRATION (PARAMETERS);
DIAGNOSTIC ERROR;
DRUG DETERMINATION;
DRUG TISSUE LEVEL;
FETUS (ANATOMY);
FLOW RATE;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LIQUID CHROMATOGRAPHY;
MATERNAL BLOOD;
PHASE TRANSITION;
PLACENTA;
POLARITY SWITCHING LIQUID CHROMATOGRAPHY;
SEPARATION TECHNIQUE;
TANDEM MASS SPECTROMETRY;
VALIDATION PROCESS;
WATER ANALYSIS;
|
EID: 1242294428
PISSN: 09514198
EISSN: None
Source Type: Journal
DOI: 10.1002/rcm.1329 Document Type: Article |
Times cited : (13)
|
References (26)
|